What consequence might occur if a client has agranulocytosis while taking clozapine?

Agranulocytosis is a serious condition characterized by a dangerously low level of neutrophils, a type of white blood cell that plays a crucial role in the immune system's ability to fight off infections. When a client experiences agranulocytosis while taking clozapine, there is a significant risk of infections due to the compromised immune response. Clozapine is an atypical antipsychotic that has been associated with this potentially life-threatening side effect; thus, close monitoring of white blood cell counts is essential in clients receiving this medication.

The implication of heightened infection risk is particularly critical, as individuals with agranulocytosis may not only become ill more easily, but infections could also progress more rapidly and significantly than in those with a healthy immune system. Preventive measures, such as regular blood monitoring and educating the client about signs of infection, become paramount in managing the risk associated with this condition.